Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union ...
Biomerica (BMRA) announces that its food intolerance products for Crohn’s Disease and Ulcerative Colitis have achieved CE-marking under the ...
The tests identify specific foods that may trigger inflammation in patients with Crohn's disease and ulcerative colitis.
Biomerica’s retail follower count on Stocktwits has climbed nearly 5% over the past year, while message volume has soared over a thousand-fold, even as the stock has shed more than 31% in value ...
Feb. 19, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel Syndrome (IBS ...
IRVINE, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global leader in advanced medical diagnostic solutions, is proud to announce that patients with Irritable Bowel ...
Biomerica primarily focuses on gastrointestinal and inflammatory diseases where the Company has multiple diagnostic and therapeutic products in development. The Private Securities Litigation ...
As the S&P 500 reaches new heights and the Nasdaq Composite hovers near record levels, investors are closely watching market dynamics that continue to evolve amid mixed trading signals. In this ...
Apple, Rivian, Unitedhealth, Biomerica, Tesla: Why These 5 Stocks Are On Investors' Radars Today U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over ...